SuperNOVA Clinical Stenting Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 299 participants.
Also called NCT01292928
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 299 participants
- Sponsor
- Registry
-
NCT01292928
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Austria, Belgium, Canada, Germany, Japan, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01292928. Allocation not applicable; no masking; primary purpose treatment. Start 2011-04 (registry gives no type); primary completion 2014-07 (actual). Results posted on 2016-01-20.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- SuperNOVA Clinical Stenting Trial
- Condition
- Atherosclerosis of Native Arteries of the Extremities, Unspecified
- Intervention (Device)
- Stent implantation
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct01292928- Content hash
40f3966065f7d30c455f2f73c7278adc5d4dcdeb201a2e5f9550716a91d573a6